WOBURN, Mass., Oct. 23, 2023 NeuroMetrix, Inc. announced today that it plans to issue its Q3 2023 business and financial highlights before the opening of the market on October 26, 2023. The.
StockNews.com began coverage on shares of NeuroMetrix (NASDAQ:NURO – Free Report) in a report published on Saturday morning. The firm issued a sell rating on the medical device company’s stock. NeuroMetrix Trading Up 2.2 % Shares of NURO stock opened at $0.66 on Friday. NeuroMetrix has a 12 month low of $0.60 and a 12 […]
Bioelectric Medicine Market to Generate Revenue of US$ 39 3 Billion By 2031 | Astute Analytica | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The neurostimulation devices market is expected to grow by USD 6.25 billion from 2022 to 2027. In addition, the momentum of the market will.
StockNews.com assumed coverage on shares of NeuroMetrix (NASDAQ:NURO – Free Report) in a report issued on Friday. The brokerage issued a sell rating on the medical device company’s stock. NeuroMetrix Trading Down 5.0 % NASDAQ NURO opened at $0.64 on Friday. The stock has a market cap of $5.46 million, a P/E ratio of -0.89 […]